Diagonal Bio AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagonal Bio AB have?
Diagonal Bio AB has 1,639,322,000 shares outstanding.
What happened to Diagonal Bio AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Diagonal Bio AB?
Currently, no hedge funds are holding shares in DE:9F1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Diagonal Bio AB
Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.